Literature DB >> 33720975

Outcomes of COVID-19 patients with comorbidities in southwest Nigeria.

Akin Osibogun1,2, Mobolanle Balogun2, Akin Abayomi1,3, Jide Idris1, Yetunde Kuyinu4, Oluwakemi Odukoya2, Ololade Wright4, Remi Adeseun1, Bamidele Mutiu5, Babatunde Saka5, Nike Osa1, Dayo Lajide1, Ismael Abdus-Salam1, Bodunrin Osikomaiya6, Oluwatosin Onasanya7, Bisola Adebayo4, Yewande Oshodi8, Sunday Adesola9, Olu Adejumo9, Olufemi Erinoso10, Hussein Abdur-Razzaq3, Abimbola Bowale9, Kingsley Akinroye11.   

Abstract

BACKGROUND: Data on the comorbidities that result in negative outcomes for people with COVID-19 are currently scarce for African populations. This study identifies comorbidities that predict death among a large sample of COVID-19 patients from Nigeria.
METHODS: This was a retrospective analysis of medical records for 2184 laboratory confirmed cases of COVID-19 in Lagos, southwest Nigeria. Extracted data included age, sex, severity of condition at presentation and self-reported comorbidities. The outcomes of interest were death or discharge from facility.
RESULTS: Most of the cases were male (65.8%) and the median age was 43 years (IQR: 33-55). Four hundred and ninety-two patients (22.5%) had at least one comorbidity and the most common amongst them were hypertension (74.2%) and diabetes (30.3%). The mortality rate was 3.3% and a significantly higher proportion of patients with comorbidities died compared to those with none. The comorbidities that predicted death were hypertension (OR: 2.21, 95%CI: 1.22-4.01), diabetes (OR: 3.69, 95% CI: 1.99-6.85), renal disease (OR: 12.53, 95%CI: 1.97-79.56), cancer (OR: 14.12, 95% CI: 2.03-98.19) and HIV (OR: 1.77-84.15].
CONCLUSION: Comorbidities are prevalent and the associated risk of death is high among COVID-19 patients in Lagos, Nigeria. Public enlightenment, early identification and targeted care for COVID-19 cases with comorbidities are recommended as the pandemic evolves.

Entities:  

Year:  2021        PMID: 33720975     DOI: 10.1371/journal.pone.0248281

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  16 in total

Review 1.  COVID-19 Case Fatality Rate and Factors Contributing to Mortality in Ethiopia: A Systematic Review of Current Evidence.

Authors:  Derara Girma; Hiwot Dejene; Leta Adugna; Mengistu Tesema; Mukemil Awol
Journal:  Infect Drug Resist       Date:  2022-07-04       Impact factor: 4.177

2.  The Role of Simple Blood Tests and a Modified Chest X-Ray Scoring System in Assessing the Severity Disease and Mortality Risk in COVID-19 Patients in a Secondary Hospital, Indonesia.

Authors:  Soedarsono Soedarsono; Deri Yunita; Emma Ayu Lirani; Robitha Kartika Sari; Yoga Indrawan Pratama; Afifah Listiati; Bambang Supriyanto
Journal:  Int J Gen Med       Date:  2022-06-30

3.  Predictors and time to recovery from COVID-19 among patients attended at the treatment centers in Ekiti State, South West, Nigeria.

Authors:  Oluwabunmi Samuel Ibitoye; Yusuff Akinkunmi Olasunkanmi; Tubosun Alex Olowolafe; Aderemi Temitayo Olabode; Mobolaji Modinat Salawu; Rotimi Felix Afolabi
Journal:  Pan Afr Med J       Date:  2022-05-09

4.  A retrospective survey of death care practices and procedures in handling suspected and confirmed COVID-19 deceased bodies in the mortuary of a resource-poor tertiary healthcare facility in Uyo, South-South Nigeria.

Authors:  Uchechukwu Brian Eziagu; Ikwo Kudamnya; Asukwo Etim Onukak; Chinedu Onwuka Ndukwe
Journal:  Pan Afr Med J       Date:  2022-03-04

5.  Associations between COVID-19 testing status, non-communicable diseases and HIV status among residents of sub-Saharan Africa during the first wave of the pandemic.

Authors:  Morenike O Folayan; Roberto Ariel Abeldaño Zuñiga; Jorma I Virtanen; Maha El Tantawi; Giuliana Florencia Abeldaño; Anthonia Omotola Ishabiyi; Mohammed Jafer; Nuraldeen Maher Al-Khanati; Mir Faeq Ali Quadri; Muhammad Abrar Yousaf; Passent Ellakany; Ntombifuthi Nzimande; Eshrat Ara; Zumama Khalid; Folake Barakat Lawal; Joanne Lusher; Bamidele O Popoola; Ifeoma Idigbe; Abeedha Tu-Allah Khan; Martin Amogre Ayanore; Balgis Gaffar; Bamidele Emmanuel Osamika; Nourhan M Aly; Nicaise Ndembi; Annie Lu Nguyen
Journal:  BMC Infect Dis       Date:  2022-06-13       Impact factor: 3.667

Review 6.  Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis.

Authors:  Celestin Danwang; Jean Jacques Noubiap; Annie Robert; Jean Cyr Yombi
Journal:  AIDS Res Ther       Date:  2022-01-14       Impact factor: 2.250

7.  Epidemiological comparison of the first and second waves of the COVID-19 pandemic in Nigeria, February 2020-April 2021.

Authors:  Oluwatosin Wuraola Akande; Kelly Osezele Elimian; Ehimario Igumbor; Lauryn Dunkwu; Chijioke Kaduru; Olubunmi Omowunmi Olopha; Dabri Olohije Ohanu; Lilian Nwozor; Emmanuel Agogo; Olusola Aruna; Muhammad Shakir Balogun; Olaolu Aderinola; Anthony Ahumibe; Chinedu Arinze; Sikiru Olanrewaju Badaru; William Nwachukwu; Augustine Olajide Dada; Cyril Erameh; Khadeejah Hamza; Tarik Benjamin Mohammed; Nnaemeka Ndodo; Celestina Obiekea; Chinenye Ofoegbunam; Oladipo Ogunbode; Cornelius Ohonsi; Ekaete Alice Tobin; Rimamdeyati Yashe; Afolabi Adekaiyaoja; Michael C Asuzu; Rosemary Ajuma Audu; Muhammad Bashir Bello; Shaibu Oricha Bello; Yusuf Yahaya Deeni; Yahya Disu; Gbenga Joseph; Chidiebere Ezeokafor; Zaiyad Garba Habib; Christian Ibeh; Ifeanyi Franklin Ike; Emem Iwara; Rejoice Kudirat Luka-Lawal; Geoffrey Namara; Tochi Okwor; Lois Olajide; Oluwafunke Olufemi Ilesanmi; Solomon Omonigho; Ferdinand Oyiri; Koubagnine Takpa; Nkem Usha Ugbogulu; Priscilla Ibekwe; John Oladejo; Elsie Ilori; Chinwe Lucia Ochu; Chikwe Ihekweazu
Journal:  BMJ Glob Health       Date:  2021-11

8.  Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis.

Authors:  Ben Bepouka; Hippolyte Situakibanza; Modibo Sangare; Madone Mandina; Nadine Mayasi; Murielle Longokolo; Ossam Odio; Donatien Mangala; Fiston Isekusu; Jean Marie Kayembe; Jean Nachega; Marcel Mbula
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-01-27       Impact factor: 3.738

9.  Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report.

Authors:  Alireza Ala; Solomon Habtemariam; Samad Shams Vahdati; Aysa Rezabakhsh
Journal:  Future Virol       Date:  2022-02-11       Impact factor: 1.831

10.  Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?

Authors:  Mohamad Saifudin Hakim; Hendra Wibawa; Vivi Setiawaty; Ika Trisnawati; Endah Supriyati; Riat El Khair; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Dwi Aris Agung Nugrahaningsih; Yunika Puspadewi; Dyah Ayu Puspitarani; Irene Tania; Khanza Adzkia Vujira; Muhammad Buston Ardlyamustaqim; Gita Christy Gabriela; Laudria Stella Eryvinka; Bunga Citta Nirmala; Esensi Tarian Geometri; Abirafdi Amajida Darutama; Anisa Adityarini Kuswandani; Sri Handayani Irianingsih; Siti Khoiriyah; Ina Lestari; Nur Rahmi Ananda; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  Front Med (Lausanne)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.